drugset / Trial / NCT01374113
Safinamide Renal Impairment Trial
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The primary purpose of the trial is to investigate the pharmacokinetics (behaviour of the compound in the body) of safinamide in subjects with different degrees of renal impairment in comparison to matched subjects with normal renal function.
Timeline
- Start
- 2011-06
- Primary completion
- 2011-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Safinamide | Small molecule | 50 mg | — |